Agenda* The 9th International Congress on Cutaneous Adverse Drug Reactions (iscar 2015)
|
|
|
- Polly May
- 5 years ago
- Views:
Transcription
1 1 of 5 Agenda* The 9th International Congress on Cutaneous Adverse Drug Reactions (iscar 2015) Co-chairs: Dr. Neil H. Shear at the 23rd World Congress of Dermatology in Vancouver, Canada. Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto Medical School. Toronto, Canada. Dr. Wen-Hung Chung The Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Chang Gung University. Taoyuan, Taiwan Vice-chair: Dr. Roni P. Dodiuk-Gad Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada. Ha emek Medical Center, Afula, Israel. Time Topic Speaker Affiliation 8-8:15am Opening remarks Dr. Neil H. Shear Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada Pharmacogenomics and Severe Cutaneous Adverse Drug Reactions (SCAR) Dr. Lois A La Grenade - Division of Pharmacovigilance, Office of Surveillance & Epidemiology, Center for Drug Evaluation & Research, US FDA, Silver Spring, USA Dr. Simon A. Mallal - Institute for Immunology and Infectious Diseases, Murdoch University, Western Australia 8:15-8:30am HLAs and SCAR- Dr. Elizabeth Phillips Vanderbilt University Medical Center, Nashville, TN, USA, and the Institute for Immunology and Infectious Diseases, Murdoch, WA, Australia
2 2 of 5 8:30-8:45am Pharmacovigilance Dr. Lois A La Grenade Division of Pharmacovigilance, Office of Surveillance & Epidemiology, Center for Drug Evaluation & Research, US FDA, Silver Spring, USA 8:45-9:00am Pathomechanism of allopurinol-induced hypersensitivity reactions Dr. Shuen-Iu Hung Department & Institute of Pharmacology, National Yang-Ming University, Taipei, Taiwan 9:00-9:15am 9:15-9:30am 9:30-9:45am Pharmacogenomics and SCAR- Q+A Dr. Lois A La Grenade, Dr. Simon A. Mallal iscar 2015 Group Consensus on Pharmacogenomics and SCAR Coffee Break Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/ Drug-Induced Hypersensitivity Syndrome (DIHS) Dr. Eishin Morita - Shimane University Faculty of Medicine, Shimane, Japan Dr. Sylvia H. Kardun - University Medical Center Groningen, Reference Center for cutaneous adverse drug reactions, Groningen, The Netherlands 9:45-10:00am 10:00-10:15am 10:15-10:30am DRESS /DIHS- Pathogenesis- DRESS/DIHS- Clinical aspects and In vitro tests- DRESS/DIHS short and long term complications Dr. Tetsuo Shiohara Dr. Sima Halevy Dr. Yoko Kano Kyorin University School of Medicine, Tokyo, Japan Soroka University Medical Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel Kyorin University School of Medicine, Tokyo, Japan 10:30-10:45am Management of DRESS - cutaneous adverse drug reaction working group of the French Society of Dermatology Dr. Annick Barbaud Dermatology and Allergy Department, Brabois Hospital, University Hospital of Nancy, Lorraine University, France
3 3 of 5 10:45-11:00pm 11:00-11:15 11:15-12:00pm DRESS /DIHS Q+A Dr.Eishin Morita, Dr. Sylvia H. Kardaun iscar 2015 Group Consensus on DRESS /DIHS Lunch break Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis (SJS/TEN) Dr. Jean-Claude Roujeau - Université Paris-Est Créteil (UPEC), France Dr. Abe Riichiro - Hokkaido University Graduate School of Medicine, Sapporo, Japan 12:00- Dr. Maja 12:15pm Mockenhaupt 12:15-12:30 pm 12:30-12:45pm Stevens-Johnson syndrome and toxic epidermal necrolysis- Epidemiology and clinical presentation- Stevens-Johnson syndrome and toxic epidermal necrolysis- Pathogenesis and Treatment- IVIG clinical trial for SJS/TEN in Japan Dr. Wen-Hung Chung Dr. Michiko Aihara University Freiburg Medical Center, Freiburg, Germany Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospitals, Taipei, Linkou, and Keelung, Taiwan Yokohama City University School of Medicine, Kanagawa, Yokohama, Japan 12:45-1:00pm 1:00-1:15pm Anti-TB drugs induced Stevens- Johnson syndrome and toxic epidermal necrolysis: Clinical assessments and genetic links Recurrence and mortality following SJS/TEN Dr. Rannakoe J. Lehloenya Dr. Yaron Finkelstein Division of Dermatology, Department of Medicine, University of Cape Town, South Africa Paediatric Emergency Medicine Clinical Pharmacology and Toxicology, The Hospital for Sick Children, Toronto, Canada.
4 4 of 5 1:15-1:30 pm 1:30-1:45pm SJS/TEN Q+A Dr. Jean-Claude Roujeau, Dr. Abe Riichiro iscar 2015 Group Consensus on SJS/TEN Acute Generalised Exanthematous Pustulosis (AGEP) Dr. Pierre Wolkenstein - Division Cancers Immunity Transplantation Infections, Henri- Mondor Hospital, University Paris Est Créteil, Créteil Cedex France 1:45- Dr. Lars E. 2:00pm French 2:00-2:15pm 2:15-2:30pm 2:30-2:45pm 2:45-3:00pm 3:00-3:20pm Acute generalized exanthematous pustulosis- A diagnostic challenge: AGEP Vs other pustular eruptions Systemic involvement of acute generalized exanthematous pustulosis Dr. Batya Davidovici Dr. Claire Hotz Department of Dermatology Zurich University Hospital, Zürich, Switzerland Depatment of Dermatology, Rabin Medical Center, Sackler Faculty of Medicine, Tel Aviv, Israel AP-HP, Hôpital Henri-Mondor, Créteil, France AGEP Q+A Dr. Pierre Wolkenstein iscar 2015 Group Consensus on AGEP Coffee Break More cutaneous adverse drug reactions Dr.Rosaline Hui - Chang Gung Memorial Hospital at Taipei, Taiwan Dr. Chih-Hsun Yang - Chang Gung Memorial Hospital, Taipei, Taiwan 3:20-3:35pm 3:35-3:50pm Dermatologic Side Effects of Cancer Treatment Causality in ADR Dr. Mario E. Lacouture Dr. Raed Alhusayen Memorial Sloan Kettering Cancer Center, NYC, USA Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences
5 5 of 5 Centre, University of Toronto, Toronto, Canada 3:50-4:05pm 4:05-4:20pm 4:20-5pm In vitro and In vivo assessments for SCAR- Dr. Marc Vocanson INSERM U851, IFR 128, BioSciences Lyon-Gerland, Lyon Cedex, France. More cutaneous adverse drug reactions Q+A Rosaline Hui, Dr. Chih-Hsun Yang Closing Remarks, Distinguished Contribution Awards Ceremony and Group Photo Presented by Dr. Wen-Hung Chung and Dr. Neil H. Shear *Not all speakers are confirmed. Topics and speakers may change.
Elizabeth J. Phillips - Professor of Medicine and Pharmacology, John A. Oates Chair in Clinical Research, Vanderbilt University Medical Center, USA
November 10,2018 Opening OP 9:10 Eishin Morita - Shimane University, Session 1 Moderators Koji Hashimoto & Maja Mockenhaupt SCAR1-1 9:15 SCAR1-2 9:40 SCAR1-3 10:05 Maja Mockenhaupt - Medical Center and
Welcome messages. We would like to welcome you to Paris, the magnificent capital of France. Pascal Demoly Jean-Claude Roujeau. DHM3 Co-Presidents
Committees DHM3 Co-Presidents Pascal Demoly (Montpellier, France) Jean-Claude Roujeau (Paris, France) Organising Committee Pascal Demoly (Montpellier, France) Jean-Claude Roujeau (Paris, France) Pierre
Skin Manifestations of Drug Reactions
Skin Manifestations of Drug Reactions Dr Carol Hlela, Division of Dermatology Department of Medicine, University of Cape Town and Red Cross Children s Hospital What are the Skin Manifestations of Drug
Medical Center and Medical Faculty-University of Freiburg, Germany
9:15-9:40 November 10, 2018 Invited Speaker SCAR1-1 Epidemiology of severe cutaneous adverse reactions SCAR Maja Mockenhaupt Medical Center and Medical Faculty-University of Freiburg, Germany Stevens-Johnson
University of Groningen
University of Groningen Toxic epidermal necrolysis, DRESS, AGEP Bouvresse, Sophie; Valeyrie-Allanore, Laurence; Ortonne, Nicolas; Konstantinou, Marie Pauline; Kardaun, Sylvia H.; Bagot, Martine; Wolkenstein,
33 rd Annual Meeting of the Israel Society of Dermatology and Venereology Meridian Hotel, Dead Sea, Israel, June 16-17, 2010
First Announcement and Call for Papers Dear Colleagues, The Department of of Soroka University Medical Center, takes great pleasure to invite you to attend the 33rd Annual Meeting of the Israel Society
Title: Cutaneous Adverse Drug Reactions in Indian population: A systematic review
Title: Cutaneous Adverse Drug Reactions in Indian population: A systematic review Review question(s) To carry out a systematic review of the published evidence of the cutaneous adverse drug reactions in
DHM 2018, Drug Hypersensitivity Meeting April 2018 Amsterdam, The Netherlands. Scientific Programme
DHM 2018, Drug Hypersensitivity Meeting 19-21 April 2018 Amsterdam, The Netherlands Scientific Programme Thursday, 19 April 2018 12:00-13:45 Registration 13:45-14:00 Welcome Address by DHM 2018 Chair Ingrid
Severe Cutaneous Adverse Reactions Related to Systemic Antibiotics
MAJOR ARTICLE Severe Cutaneous Adverse Reactions Related to Systemic Antibiotics Ying-Fang Lin, 1 Chih-Hsun Yang, 2,3 Hu Sindy, 1,3 Jing-Yi Lin, 2,3 Chung-Yee Rosaline Hui, 2,3 Yun-Chen Tsai, 2 Ting-Shu
Cutaneous drug eruptions are seen commonly
REVIEW ARTICLE Cutaneous drug reactions in children Sandipan Dhar, Raghubir Banerjee, Rajib Malakar Department of Pediatric Dermatology, Institute of Child Health, Kolkata, West Bengal, India ABSTRACT
An Evidenced-Based Approach to the Adult with a Morbilliform Eruption
Relatively An Evidenced-Based Approach to the Adult with a Morbilliform Eruption Ben Kaffenberger, MD Assistant Professor, Dermatology Director, Inpatient Dermatology Consult Service Ohio State University
Pathophysiology of autoimmune and allergic diseases. Hypersensitivity reactions type II type IV
Pathophysiology of autoimmune and allergic diseases Hypersensitivity reactions type II type IV Audrey NOSBAUM, Florence HACARD, Marc VOCANSON, Frédéric BERARD, Jean François NICOLAS Allergologie et Immunologie
(12) Patent Application Publication (10) Pub. No.: US 2012/ A1
(19) United States (12) Patent Application Publication (10) Pub. No.: US 2012/0329045 A1 Chung et al. US 20120329.045A1 (43) Pub. Date: (54) (75) (73) (21) (22) (63) RISK ASSESSMENT FOR PHENYTON-INDUCED
New product information wording Extracts from PRAC recommendations on signals
12 October 2017 EMA/PRAC/610988/2017 Pharmacovigilance Risk Assessment Committee (PRAC) New product information wording Extracts from PRAC recommendations on signals Adopted at the 25-29 September 2017
OXCARBAZEPINE-INDUCED STEVENS-JOHNSON SYNDROME: A CASE REPORT
OXCARBAZEPINE-INDUCED STEVENS-JOHNSON SYNDROME: A CASE REPORT Lung-Chang Lin, 1,2 Ping-Chin Lai, 3 Sheau-Fang Yang, 4 and Rei-Cheng Yang 1,5 Departments of 1 Pediatrics and 4 Pathology, Kaohsiung Medical
AOU Ospedali Riuniti - Ancona
AOU Ospedali Riuniti - Ancona Ospedale Materno-Infantile di Alta Specializzazione G. Salesi UOC Pediatria Allergia a farmaci e infezioni: tra coesistenza e casualità fabrizio franceschini Drug Hypersensitivity
Danger Signs in Drug Hypersensitivity
Danger Signs in Drug Hypersensitivity Kathrin Scherer, MD*, Andreas J. Bircher, MD KEYWORDS Drug hypersensitivity Adverse drug reaction Clinical danger signs Immediate-type hypersensitivity Delayed-type
Stevens Johnson Syndrome: How Diagnosis Impacts Disease Course
Southern Adventist Univeristy KnowledgeExchange@Southern Graduate Research Projects Nursing 12-4-2015 Stevens Johnson Syndrome: How Diagnosis Impacts Disease Course Sharon K. Hart Southern Adventist University,
Cutaneous drug reactions
Maintenance of Certification clinical management series Series editor: James T. Li, MD, PhD Cutaneous drug reactions David A. Khan, MD Dallas, Tex INSTRUCTIONS Credit can now be obtained, free for a limited
Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study
open access Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study Tai-Ming Ko, 1,2 Chang-Youh Tsai, 3,4 Shih-Yang
Cutaneous drug reactions to antiepileptic drugs and relation with HLA alleles in the Turkish population
O R I G I N A L A R T I C L E Eur Ann Allergy Clin Immunol Vol 50, N 1, 36-41, 2018 S. Büyüköztürk 1, Ç. Kekik 2, A.Z. Gökyiğit 3, F.İ. Tezer Filik 4i, G. Karakaya 4, S. Saygı 4i, A.B. Dursun 5, S. Kirbaş
PEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW
PEER REVIEW HISTORY BMJ Paediatrics Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form and are provided with free text boxes to elaborate
Skin and in vitro tes<ng in DRESS, SJS/TEN & AGEP: Possibili<es and limita<ons
Skin and in vitro tes
Pathomechanism of Severe Drug Allergy
Pathomechanism of Severe Drug Allergy Werner J. Pichler, MD Division Allergology, RIA, Inselspital, University of Bern, CH 3010 Bern Switzerland ADR-AC GmbH Adverse Drug Reactions Analysis and Consulting
Sirolimus - Versus Paclitaxel-Eluting Stents: Long-Term Clinical Results in Acute Myocardial Infarction
Sirolimus - Versus Paclitaxel-Eluting Stents: Long-Term Clinical Results in Acute Myocardial Infarction Danny Dvir, Abid Assali, Igal Teplisky, Hana Vaknin-Assa, Eli I Lev, Eldad Rechavia, David Brosh,
Warfarin-induced toxic epidermal necrolysis in combination therapy of Henoch- Schönlein purpura nephritis: a case report
Kasahara et al. BMC Nephrology (2017) 18:237 DOI 10.1186/s12882-017-0648-9 CASE REPORT Open Access Warfarin-induced toxic epidermal necrolysis in combination therapy of Henoch- Schönlein purpura nephritis:
Prevalence and pattern of adverse cutaneous drug reactions presenting to a tertiary care hospital
International Journal of Research in Dermatology Janardhan B et al. Int J Res Dermatol. 2017 Mar;3(1):74-78 http://www.ijord.com Original Research Article DOI: http://dx.doi.org/10.18203/issn.2455-4529.intjresdermatol20164248
RESEARCH REPOSITORY.
RESEARCH REPOSITORY This is the author s final version of the work, as accepted for publication following peer review but without the publisher s layout or pagination. The definitive version is available
Prevention of severe cutaneous adverse drug reactions: the emerging value of pharmacogenetic screening
CMAJ Cases Prevention of severe cutaneous adverse drug reactions: the emerging value of pharmacogenetic screening Suran L. Fernando MB BS PhD, Andrew J. Broadfoot MB BS Previously published at www.cmaj.ca
Accepted Manuscript. Letter to the Editor. Reply to: From the CUPIC study: Great times are not coming (?)
Accepted Manuscript Letter to the Editor Reply to: From the CUPIC study: Great times are not coming (?) Christophe Hezode, Helene Fontaine, Yoann Barthe, Fabrice Carrat, Jean-Pierre Bronowicki PII: S0-()00-
THE SPECTRUM OF HISTOPATHOLOGICAL FEATURES IN ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS: A STUDY OF 102 CASES
These articles have been accepted for publication in the British Journal of Dermatology and are currently being edited and typeset. Readers should note that articles published below have been fully refereed,
Herbal and homeopathic products, often considered natural and non-toxic, can also cause adverse drug reactions.
Idiosyncratic and potentially serious cutaneous adverse drug reactions (CADRs), although relatively rare, account for significant morbidity and mortality. RANNAKOE J LEHLOENYA, BSc, MB ChB, FCDerm (SA)
allergy Asia Pacific Stevens-Johnson syndrome and toxic epidermal necrolysis in Dr. Hasan Sadikin General Hospital Bandung, Indonesia from
pissn -876 eissn -868 Original Article Asia Pac Allergy 6;6:-7 Stevens-Johnson syndrome and toxic epidermal necrolysis in Dr. Hasan Sadikin General Hospital Bandung, Indonesia from 9 Oki Suwarsa *, Wulan
International Consensus (ICON) on Drug Allergy
International Consensus (ICON) on Drug Allergy Allergy 2014; 69: 420 437 Pascal Demoly, N. Franklin Adkinson, Knut Brockow, Mariana Castells, Anca M. Chiriac, Paul A. Greenberger, David A. Khan, David
Analysis of Individual Case Safety Reports of Severe Cutaneous Adverse Reactions in Korea
Original Article Yonsei Med J 2019 Feb;60(2):208-215 pissn: 0513-5796 eissn: 1976-2437 Analysis of Individual Case Safety Reports of Severe Cutaneous Adverse Reactions in Korea Min-Gyu Kang 1,2,3, Kyung-Hee
Alpelisib (ALP) + Fulvestrant (FUL) for Advanced Breast Cancer (ABC): Phase 3 SOLAR-1 Trial Results
Alpelisib (ALP) + Fulvestrant (FUL) for Advanced Breast Cancer (ABC): Phase 3 SOLAR-1 Trial Results Dejan Juric, 1* Eva Maria Ciruelos, 2 Gabor Rubovszky, 3 Mario Campone, 4 Sibylle Loibl, 5 Hope S. Rugo,
REGISCAR INTERNATIONAL REGISTRY OF SEVERE CUTANEOUS ADVERSE REACTIONS (SCAR) TO DRUGS AND COLLECTION OF BIOLOGICAL SAMPLES
REGISCAR INTERNATIONAL REGISTRY OF SEVERE CUTANEOUS ADVERSE REACTIONS (SCAR) TO DRUGS AND COLLECTION OF BIOLOGICAL SAMPLES study protocol written by Maja Mockenhaupt, Dokumentationszentrum schwerer autreaktionen
Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. Supplementary online-material Supplementary Table S1: Detailed descriptive analysis
Acute generalized exanthematous pustulosis in the ambulatory care setting
www.edoriumjournals.com CASE REPORT PEER REVIEWED OPEN ACCESS Acute generalized exanthematous pustulosis in the ambulatory care setting LT Mark C. Hubbard, LT John C. Walsh, LCDR Megan A. Brelsford ABSTRACT
Adverse Cutaneous Drug Eruptions
Chemical Immunology and Allergy 97 Adverse Cutaneous Drug Eruptions Bearbeitet von L.E. French, H. Renz 1. Auflage 2012. Buch. XIV, 240 S. Hardcover ISBN 978 3 8055 9970 2 Gewicht: 790 g Weitere Fachgebiete
International Journal of Basic & Clinical Pharmacology. Profile of cutaneous adverse drug reactions of carbamazepine
Print ISSN: 2319-2003 Online ISSN: 2279-0780 IJBCP International Journal of Basic & Clinical Pharmacology DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20175211 Original Research Article Profile of cutaneous
AJRCCM Articles. Published on February 23, 2012
Fever Control Using External Cooling in Septic Shock: A Randomized Controlled Trial Frédérique Schortgen, Karine Clabault, Sandrine Katsahian, Jerome Devaquet, Alain Mercat, Nicolas Deye, Jean Dellamonica,
Management of carbamazepine induced drug reaction with eosinophlia and systemic symptoms in Mediheal hospital- Nakuru, Kenya: a case report
International Journal of Research in Dermatology http://www.ijord.com Case Report DOI: http://dx.doi.org/10.18203/issn.2455-4529.intjresdermatol20184469 Management of carbamazepine induced drug reaction
3 Medicine; 4 Pediatrics; 5 Pathology, Schulich School of Medicine and Dentistry; 6 Siebens-Drake Medical Research
SEVERE BULLOUS HYPERSENSITIVITY REACTIONS AFTER EXPOSURE TO CARBAMAZEPINE IN A HAN-CHINESE CHILD WITH A POSITIVE HLA- B*1502 AND NEGATIVE IN VITRO TOXICITY ASSAYS: EVIDENCE FOR DIFFERENT PATHOPHYSIOLOGICAL
Risk Factors and Management of Mood Stabilizer-associated Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Mini-review
140 Taiwanese Journal of Psychiatry (Taipei) Vol. 25 No. 3 2011 Overview Risk Factors and Management of Mood Stabilizer-associated Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Mini-review Gen-Tang
REGISTRY OF SEVERE CUTANEOUS ADVERSE REACTIONS TO DRUGS AND COLLECTION OF BIOLOGICAL SAMPLES. R e g i S C A R PATIENT'S DATA. Age country of birth
REGISTRY OF SEVERE CUTANEOUS ADVERSE REACTIONS TO DRUGS AND COLLECTION OF BIOLOGICAL SAMPLES R e g i S C A R PATIENT'S DATA Initials of the patient date of birth Age country of birth Gender male female
They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:
bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest
Drug Allergy A Guide to Diagnosis and Management
Drug Allergy A Guide to Diagnosis and Management (Version 1 April 2015 updated April 2018) Author: Jed Hewitt Chief Pharmacist, Governance & Professional Practice Date of Preparation: April 2015 Updated:
Consensus Conference on Clinical Practice in Chronic GVHD Regensburg
Consensus Conference on Clinical Practice in Chronic GVHD Regensburg 6. - 7. November 2009 Hörsaal A2 University of Regensburg Stem cell transplantation program Organisation: Prof. Dr. R. Andreesen, Prof.
Review Article Treatments for Severe Cutaneous Adverse Reactions
Hindawi Journal of Immunology Research Volume 2017, Article ID 1503709, 9 pages https://doi.org/10.1155/2017/1503709 Review Article Treatments for Severe Cutaneous Adverse Reactions Yung-Tsu Cho and Chia-Yu
Department of Allergy and Immunology. Drug allergy. Dean Tey Paediatric Allergist & Immunologist FRACP LECTURE 2014
Drug allergy Dean Tey Paediatric Allergist & Immunologist FRACP LECTURE 2014 Outline 1. Background 2. SCAR 3. Mechanism of action 4. Assessment on history 5. Investigations 6. Drug desensitisation 7. Specific
Mechanisms of Drug Hypersensitivity Reactions
18/5/213 Mechanisms of Drug Hypersensitivity Reactions Munir Pirmohamed NHS Chair of Pharmacogenetics Department of Molecular and Clinical Pharmacology Institute of Translational Medicine University of
A 10-years retrospective study on Severe Cutaneous Adverse Reactions (SCARs) in a tertiary hospital in Penang, Malaysia
ORIGINAL ARTICLE A 10-years retrospective study on Severe Cutaneous Adverse Reactions (SCARs) in a tertiary hospital in Penang, Malaysia Chai Har Loo, MRCP, Wooi Chiang Tan, AdvMDerm, Yek Huan Khor, AdvMDerm,
Stevens Johnson Syndrome and Toxic Epidermal Necrolysis Associated with Acetaminophen Use during Viral Infections
BRIEF COMMUNICATION http://dx.doi.org/10.4110/in.2016.16.4.256 pissn 1598-2629 eissn 2092-6685 Stevens Johnson Syndrome and Toxic Epidermal Necrolysis Associated with Acetaminophen Use during Viral Infections
Correspondence should be addressed to Wanjarus Roongpisuthipong; rr
Dermatology Research and Practice, Article ID 237821, 5 pages http://dx.doi.org/10.1155/2014/237821 Research Article Retrospective Analysis of Corticosteroid Treatment in Stevens-Johnson Syndrome and/or
Counseling and Action
Counseling and Action Richard A. Young José F. Domene Ladislav Valach Editors Counseling and Action Toward Life-Enhancing Work, Relationships, and Identity 1 3 Editors Richard A. Young Department of Educational
DERMATOLOGIC CARE IN ONCOLOGY
Is pleased to announce: Friday, October 23, 2015 FOURTH ANNUAL DERMATOLOGIC CARE IN ONCOLOGY SYMPOSIUM CONFERENCE LOCATION MEMORIAL SLOAN KETTERING CANCER CENTER ROCKEFELLER RESEARCH LABORATORIES BOARD
CURRICULUM VITAE. Itzhak Gabizon, M.D.
November 2018 CURRICULUM VITAE Itzhak Gabizon, M.D. PERSONAL DETAILS ADDRESS: WORK ADDRESS HOME ADDRESS: Soroka University Medical Center, Beer Sheva, Israel E.mail: Gabizon@bgu.ac.il; Itzhak.gabizon@phri.ca;
RESEARCH REPOSITORY.
RESEARCH REPOSITORY This is the author s final version of the work, as accepted for publication following peer review but without the publisher s layout or pagination. The definitive version is available
PRAC recommendations on signals
25 November 2013 EMA/PRAC/693228/2013 Pharmacovigilance Risk Assessment Committee Adopted at the PRAC meeting of 4-7 November 2013 This document provides an overview of the recommendations adopted by the
Big rashes in little patients:
! Big rashes in little patients: Severe drug eruptions and cutaneous infections!! Marcia Hogeling, MD, FAAD Assistant Clinical Professor Director, Pediatric Dermatology Division of Dermatology David Geffen
Organized by. Scientific comittee
July 11 & 12, 2019 Institut Pasteur Organized by Arun Sanyal Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA Lawrence Serfaty Hôpital Hautepierre Hôpitaux Universitaires de
Pathogenesis and Management of Atopic Dermatitis
Pathogenesis and Management of Atopic Dermatitis Current Problems in Dermatology Vol. 41 Series Editors Peter Itin Basel Gregor Jemec Roskilde Pathogenesis and Management of Atopic Dermatitis Volume Editor
Les Inhibiteurs de Protéase du VHC
Les Inhibiteurs de Protéase du VHC Pr Jean-Michel Pawlotsky National Reference Center for Viral Hepatitis B, C and delta Department of Virology & INSERM U955 Henri Mondor Hospital University of Paris-Est
PULMONARY HYPERTENSION. by CLINICAL CASES. An educational event of the University of Bologna Master Degree in Pulmonary Vascular Diseases
Under the Aegis of PULMONARY HYPERTENSION by CLINICAL CASES An educational event of the University of Bologna Master Degree in Pulmonary Vascular Diseases BOLOGNA June 28-29, 2013 Palazzo dell Archiginnasio
Stevens - Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) In Sarawak: A Four Years Review
Stevens - Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) In Sarawak: A Four Years Review Yap FBB, MRCP; Wahiduzzaman M, MBBS; Pubalan M, MRCP. Egyptian Dermatology Online Journal 4 (1): 1,
Adverse drug reactions
Medications William Smith Adverse drug reactions Allergy? Side-effect? Intolerance? Background Adverse drug reactions (ADRs) vary from life-threatening anaphylaxis to minor common side-effects. Objective
New product information wording Extracts from PRAC recommendations on signals
20 July 2017 EMA/PRAC/406976/2017 Pharmacovigilance Risk Assessment Committee (PRAC) New product information wording Extracts from PRAC recommendations on signals Adopted at the 3-6 July 2017 PRAC The
PRELIMINARY PROGRAMME NHOW MILAN
PRELIMINARY PROGRAMME Via Tortona, 35-20144 Milan (Italy) 1 nd SCIENTIFIC PRELIMINARY PROGRAM Thursday, 18 October 2018 OPENING CEREMONY Chairs: M. Clerici (Italy), S. Esposito (Italy), A. Osterhaus (Germany)
SKIN REACTIONS WITH PSYCHOTROPICS: A SYSTEMATIC REVIEW
SKIN REACTIONS WITH PSYCHOTROPICS: A SYSTEMATIC REVIEW *Anderson Isaac, PharmD Candidate, 2019 Pooja Patel, PharmD Candidate, 2019 Katelyn Thomasson, PharmD Candidate, 2019 Erika Tillery, PharmD, BCPP,
ORIGINAL ARTICLE. Siew Eng Choon, FRCP 1,2, Yi Shan Der 1, Nai Liang Joel Lai 1, Evelyn Sing Ee Yu 1, Xiao Ling Yap 1, Nalini Nanu Madhavan, MBBS 2
ORIGINAL ARTICLE Clinical characteristics, culprit drugs and outcome of patients with Acute Generalised Exanthematous Pustulosis seen in Hospital Sultanah Aminah, Johor Bahru Siew Eng Choon, FRCP 1,2,
Stevens Johnson syndrome/toxic epidermal necrolysis and erythema multiforme drug related hospitalisations in a national administrative database
https://doi.org/10.1186/s13601-017-0188-1 Clinical and Translational Allergy RESEARCH Open Access Stevens Johnson syndrome/toxic epidermal necrolysis and erythema multiforme drug related hospitalisations
PULMONARY HYPERTENSION. by CLINICAL CASES. Archiginnasio Palace
Under the Aegis of European Board for Accreditation in Cardiology PULMONARY HYPERTENSION by CLINICAL CASES An educational event of the University of Bologna Master Degree in Pulmonary Vascular Diseases
HCV treament with DAA Side effects: Anemia, Skin Manifestations Pr Patrice CACOUB
HCV treament with DAA Side effects: Anemia, Skin Manifestations Pr Patrice CACOUB Service de Médecine Interne, CNRS UMR 7211, INSERM UMR 959 Université Pierre et Marie Curie Centre National de Référence
1 st Annual Treatment-Related Adverse Events Symposium: FOCUS ON MANAGEMENT. Friday, October 27, Zuckerman Research Center, New York City
1 st Annual Treatment-Related Adverse Events Symposium: FOCUS ON MANAGEMENT Friday, October 27, 2017 Zuckerman Research Center, New York City 1 st Annual Treatment-Related Adverse Events Symposium: FOCUS
NEUROLOGY AND NEUROSCIENCE
conferenceseries.com 28 th World Conference NEUROLOGY AND NEUROSCIENCE May 23-24, 2019 Zurich, Switzerland SCIENTIFIC PROGRAM conferenceseries.com 28 th world Congress NEUROLOGY AND NEUROSCIENCE Dear Colleagues,
Research in viral hepatitis: the French ANRS experience
PARIS HEPATITIS CONFERENCE January 14-15, 2013 Research in viral hepatitis: the French ANRS experience Pr. Jean-François DELFRAISSY Director of ANRS Internal Medicine Department CHU Bicêtre Paris XI -
15+ Interactive Sessions. 10+ Keynote Lectures. 40+ Scientific Sessions. 3+ Workshops. 30+ Posters. B2B Meetings PEDIATRIC CONFERENCE 2018
15+ Interactive Sessions 10+ Keynote Lectures 40+ Scientific Sessions 3+ Workshops 30+ Posters B2B Meetings PEDIATRIC CONFERENCE 2018 INTERNATIONAL PEDIATRIC INFECTIOUS DISEASES AND HEALTHCARE CONFERENCE
Research Supervision Accreditation (Paris XII University, April 2012), with congratulations
Curriculum Vitæ Virginie PRULIERE ESCABASSE Date of birth: 4 th October 1969 Place of birth: Saint Maur des Fossés, France Nationality: French Married, with 4 children email: virginie.escabasse@chicreteil.fr
STEVEN JOHNSON S SYNDROME: A BRIEF REVIEW
STEVEN JOHNSON S SYNDROME: A BRIEF REVIEW G. Ramya sree*, Sreeram Vandavasi Guru 1, E. Sam Jeeva Kumar 2 * Pharm D, Intern, P. Rami Reddy Memorial College of Pharmacy, Kadapa. 1 Pharm-D Intern, P. Rami
Severe cutaneous adverse reactions (SCAR) are life-threatening
Stevens-Johnson syndrome and toxic epidermal necrolysis: clinical patterns, diagnostic considerations, etiology, and therapeutic management Maja Mockenhaupt, MD, PhD n Abstract Severe cutaneous adverse
OTC FOUNDATION LEADERSHIP FORUM
OTC FOUNDATION LEADERSHIP FORUM SALA PLENARIA MASCAGNI HOTEL LEON D ORO VERONA, 16 17 JUNE 2016 CO-CHAIRED BY JOERG FRANKE, PRESIDENT OTCF/GA GUIDO ROCCA, PRESIDENT OTC ITALY LIST OF FACULTY CO CHAIRMEN
Feinberg Post-Program Evaluation on Global Health
Feinberg Post-Program Evaluation on Global Health Evaluation Home Page Page description: The Center for Global Health within the Feinberg School of Medicine invites you to complete the following evaluation
July 5 & 6, 2018, Paris SCIENTIFIC PROGRAM
www.paris-nash.org Dear Colleagues, We are delighted to announce the 4th Paris NASH Meeting to be held on July 5-6 th 2018. This international academic meeting is aimed to do a deep-dive into many aspects
VENUE. NMI Natural and Medical Sciences Institute at the University of Tübingen. Markwiesenstrasse 55, Reutlingen, Germany
VENUE NMI Natural and Medical Sciences Institute at the University of Tübingen Markwiesenstrasse 55, 72770 Reutlingen, Germany GPS-Coordinate: 48 29 38.24 N 9 08 02.73 O AGENDA Get updated about latest
Adverse Drug Reactions (ADRs) Outline
Adverse Drug Reactions (ADRs) Outline 1. What are Adverse Drug Reactions (ADRs)? WHAT WHY HOW 2. How important are ADRs and are they preventable? 3. What are the classifications and mechanisms of ADRs?
Infos:
SPRING MEETING SWISS SOCIETY OF PHARMACOLOGY & TOXICOLOGY Pharmacology and Toxicology of Ageing: Integrating education from basic research to clinical science April 19, 2012 Inselspital Bern Infos: http://www.swisspharmtox.ch
1. To provide an update of the diagnosis, pathophysiology, outcome, screening and management of pregnancies complicated by IUGR.
FETAL GROWTH 2016 Thursday November 17 Saturday November 19, 2016 Salter Auditorium, Hospital for Sick Children Sadowski Auditorium, Mount Sinai Hospital www.fetalgrowth2016.ca Dear Colleagues: We are
2018 THERAPEUTICS UPDATE
The Canadian Society of Pharmacology and Therapeutics 2018 THERAPEUTICS UPDATE Course Overview This one-day course on May 22, 2018 will explore emerging areas of interest in drug therapy and drug safety.
D.R.E.S.S. Syndrome An update. David H. Peng MD MPH Department of Dermatology Keck School of Medicine of USC
D.R.E.S.S. Syndrome An update David H. Peng MD MPH Department of Dermatology Keck School of Medicine of USC I have no disclosures I will be discussing off label uses for medications Maculopapular Morbilliform
Evidence for reactivation of human herpes virus 6 in generalized. lymphadenopathy in a patient with drug-induced hypersensitivity syndrome
JCM Accepts, published online ahead of print on 27 March 2013 J. Clin. Microbiol. doi:10.1128/jcm.00097-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 Evidence for reactivation
ANTIBIOTICS ACUTE RHINOSINUSITIS IN CHILDREN
MARCH 2016 DRUG ANTIBIOTICS This optimal usage guide is mainly intended f primary care health professionnals. It is provided f infmation purposes only and should not replace the clinician s judgement.
Air Pollution & mhealth Prevention and Control of Chronic Respiratory Diseases
Air Pollution & mhealth Prevention and Control of Chronic Respiratory Diseases 23 MARCH 2018 Lithuanian Seimas (Parliament) Gedimino Av. 53, Vilnius, Lithuania Organized by: EU Summit 2018 - Vilnius, Lithuania
Cutaneous Drug Reactions
Cutaneous Drug Reactions Andrei Metelitsa, MD, FRCPC, FAAD Co-Director, Institute for Skin Advancement Clinical Associate Professor, Dermatology University of Calgary, Canada Copyright 2017 by Sea Courses
After 1918: History and Politics of Influenza in the 20 th and 21 st Centuries
After 1918: History and Politics of Influenza in the 20 th and 21 st Centuries August 24-26, 2011 Amphi Condorcet Ehesp, Rennes Pr Patrick Zylberman Chair of the History of Health Ehesp Department of Social
SPINAL CORD INJURY SUMMIT. May 19-20, The Ohio State University Neurological Institute -
SPINAL CORD INJURY SUMMIT May 19-20, 2017 - The Ohio State University Neurological Institute - Meeting Venue: Ross Auditorium, Ross Heart Hospital, 452 W 12 th Ave, Columbus. Hotel: Homewood Suites, 1576
Annex I. Scientific conclusions and grounds for the variation to the terms of the Marketing Authorisation(s)
Annex I Scientific conclusions and grounds for the variation to the terms of the Marketing Authorisation(s) 1 Scientific conclusions Taking into account the PRAC Assessment Report on the PSUR(s) for ibuprofen
Carbamazepine Hypersensitivity: Progress Toward Predicting the Unpredictable
Carbamazepine Hypersensitivity: Progress Toward Predicting the Unpredictable Current Literature In Clinical Science HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans. McCormack
4 TH International LFS Association Symposium
4 TH International LFS Association Symposium hosted by The Hospital for Sick Children and in partnership with the LiFE Consortium April 25-29 TH, 2018 Toronto, Ontario Canada CONFERENCE AGENDA WEDNESDAY,
AESTHETIC MEETING 2018 DERMATOLOGY AND AESTHETIC CONGRESS. Aesthetic Dermatology: Best Foundation you can wear is Glowing Skin!
15+ Interactive Sessions 10+ Keynote Lectures 40+ Scientific Sessions 3+ Workshops 30+ Posters B2B Meetings AESTHETIC MEETING 2018 20 th World DERMATOLOGY AND AESTHETIC CONGRESS July 23-24 Kuala Lumpur,